Christian Brandts - Concepedia

Author

Christian Brandts

Also Known As

Brandts Christian, Brandts, Christian H., C Brandts, C H Brandts, C. Brandts, C. H. Brandts, C.H. Brandts, Charlotte Brandts, Christian August Brandis, Christian Brandts

236

Publications

14K

Citations

H-Index

Concepts

All Affiliations

Goethe University Frankfurt Heidelberg University University Hospital Frankfurt German Cancer Research Center Frankfurt Cancer Institute

About

Christian Brandts is an author at Goethe University Frankfurt specializing in medicine, cell biology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	24	2K
2	Health Sciences	7	7	719
3	Engineering	1	1	35
4	Natural Sciences	1	1	55
5	Public Health	1	1	126

Christian Brandts

Publications

12.5K

Citations

H-Index

Page 1

	Year	Citations
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup> Daniel J. Klionsky, Amal Kamal Abdel‐Aziz, Sara Abdelfatah, Autophagy	2021	2.5K
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia Francesco Lo‐Coco, Giuseppe Avvisati, Marco Vignetti, New England Journal of Medicine	2013	1.6K
Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With <i>FLT3</i>–Internal Tandem Duplication Mutation (SORMAIN) Andreas Burchert, Gesine Bug, Lea Fritz, Journal of Clinical Oncology	2020	538
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies Vito Annese, Laurent Beaugerie, Laurence J. Egan, Journal of Crohn s and Colitis	2015	412
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial Christoph Röllig, Hubert Serve, Andreas Hüttmann, The Lancet Oncology Sorafenib Versus PlaceboHematological MalignancyOncologyMixed-phenotype Acute LeukemiaHematology	2015	395
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial Uwe Platzbecker, Giuseppe Avvisati, Laura Cicconi, Journal of Clinical Oncology	2016	375
Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms Francis Grand, Claire Hidalgo-Curtis, Thomas Ernst, Blood	2009	369
Mislocalized Activation of Oncogenic RTKs Switches Downstream Signaling Outcomes Chunaram Choudhary, Jesper V. Olsen, Christian Brandts, Molecular Cell Signal TransductionSignaling PathwayCell RegulationReceptor Tyrosine KinaseMedicine	2009	313
Sorafenib in Combination With Intensive Chemotherapy in Elderly Patients With Acute Myeloid Leukemia: Results From a Randomized, Placebo-Controlled Trial Hubert Serve, Utz Krug, Ruth Wagner, Journal of Clinical Oncology	2013	309
Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domain Florian H. Heidel, Fian K. Solem, Frank Breitenbuecher, Blood	2005	265

Page 1